J. Talati, Jamsheer Talati

The Management of Lithiasis

The Rational Deployment of Technology
Herausgegeben:Talati, Jamsheer J.; Sutton, R. A. L.; Moazam, F.; Ahmed, M.

• Gebundenes Buch

Produktbeschreibung

The Management of Lithiasis: The Rational Deployment of Technology addresses the latest developments in the treatment of urolithiasis and biliary stones. The emphasis of the book is on the selection of the cheapest and most effective treatment and is based upon the experience of editors and authors from both the Western countries as well as developing countries in Asia. With health care budgets becoming increasingly restricted, there is a growing interest in cost-controlled and effective treatment methods.
This volume covers urinary tract calculi as well as biliary tract calculi, including epidemiology, etiology, choices in the management of calculi, efficacy and safety of treatment and the prevention of urolithiasis.

Produktdetails

• Developments in Nephrology 38
• Verlag: Springer Netherlands / Springer, Berlin
• 1997.
• Seitenzahl: 376
• Erscheinungstermin: 28. Februar 1997
• Englisch
• Abmessung: 241mm x 160mm x 26mm
• Gewicht: 725g
• ISBN-13: 9780792341987
• ISBN-10: 0792341988
• Artikelnr.: 27615413

Inhaltsangabe

Section I: Urinary Tract Calculi. Division 1: Introduction, Epidemiology, Etiology. 1. Urolithiasis: Composition, Symptoms and Pathology; A. Memon, J. Talati. 2. Radiology in Urolithiasis; S. Hussain. 3. Epidemiology of Urolithiasis in Pakistan; J. Talati, et al. 4. Urolithiasis in the Middle East: Epidemiology and Pathogenesis; S.R. El-Faqih, I. Hussain. 5. Epidemiology of Urolithiasis in the Western World; K. Hamawy, et al. 6. Metabolic and Dietary Risk Factors for Urolithiasis; R.A.L. Sutton, J. Talati. 7. Oxalate and Urolithiasis; R.A.L. Sutton. 8. Familial Clustering and Sex Incidence of Urolithiasis; J. Talati. Division 2: Choices in the Management of Calculi. 9. Decisions! Decisions! J. Talati. 10. Hazards of Open Surgery; J. Talati. 11. Choices, Limitations, Hazards and Value of Technology in the Treatment of Lithiasis; J. Talati. 12. Bioeffects of ESWL; J. Lingeman, F. Abbas. 13. Choices, Limitations, Hazards and Value of Technology: Laser Fragmentation of Urinary Calculi; G. Watson, T. Shah. 14. ESWL Today: The Spectrum of Stone Disease Treated on the Lithotriptor Today; J. Talati. 15. The Management of Renal Stones by Operation; J. Talati. 16. ESWL for Renal Stones and Management Options for Calyceal Calculi; J. Talati. 17. Percutaneous Nephrolithotony for Renal Stones; T. Shah, S. Hussain. 18. The Management of Staghorn Calculi; J. Talati. 19. Choices of Management of Ureteric Calculi; J. Talati. 20. Clinical Results of Laser Fragmentation of Ureteric Calculi; G. Watson, T. Shah. 21. The Management of Vesical and Urethral Calculi; Z. Hotiana. Division 3: Enhancement of Efficacy and Safety of Treatment. 22. Patients at Risk for Excessive Post-ESWL Bleeding; M. Khursheed, J. Talati. 23. Patients with Pacemakers; N. Baseer. 24. Safeguarding Fetus and Gonads; J. Talati. 25. Other High Risk Patients; J. Talati. 26. The Role of ESWL in Patients with Leprosy; G. Warren. 27. Factors Determining the Need for Multiple Treatments on the Dornier HM3; J.A. Belis, G. Halenda. 28. Factors Determining Need for Multiple Treatments: Decisions Based on Stone Bulk, Composition and Acoustic Efficiency; J. Talati. 30. Urinary Tract Infections, Stones and ESWL; J. Talati. 31. The Judicious Use of Stents; J. Talati, et al. 32. Protection of Hospital Personnel; J. Talati, S. Kahn. Division 4: High Technology at Affordable Cost. 33. Introduction: High Technology at Affordable Cost; J. Talati. 34. The Economics of Stone Therapy: An Economist's Views; S.K. Qureshi. 35. Selecting a Lithotriptor: Hospital Perspective; N.M. Khan, M. Dhanani. 36. Lithotriptor Sharing; R. Vleeming, et al. 37. Cost Factors in Equitable Care; J. Talati. 38. Commencing and Expanding Lithotripsy Services; J. Talati. 39. Financing a Lithotriptor; M. Kakalia. Division 5: Prevention of Urinary Tract Calculi. 40. Prevention of Urinary Tract Calculi; J. Talati. 41. The Residual Calcular Fragment; A Risk Factor For Recurrent Stone Disease; J. Talati. 42. Primary Hyperparathyroidism. Overview: Screening for Primary Hyperparathyroidism is Pertinent to the Developing World; T. Harrison. 43. The Role of Diet in the Prevention of Urolithiasis; S. Badruddin. 44. Systematic Followup of the Patient with Recurrent Nephrolithiasis &endash; a Guide for the Practicing Urologist; N.F. Dabhoiwala. 45. Followup of Urolithiasis Patients &endash; a Guide for Urologists in Developing Countries; J. Talati. Division 6: Pediatric Urolithiasis. 46. Urolithiasis in Children; Z. Nazir, F. Moazam. Section II: Biliary Tract Stones. 47. ESWL in Gall Stone Therapy: History, Present State and Expectations; L. Greiner. 48. Management of Biliary Lithiasis; M. Ahmed. Index.